EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic insights on cgMLST markers, drug resistance, and urease cluster of Proteus mirabilis strains

Shitao Lian iD, Yadong Liu iD, Songnian Hu iD, Chen Shen, Yinping Ma, Peng Yin iD, Zilong He iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.00992-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Shitao Lian und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering Medicine, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Interdisciplinary Innovation Institute of M…. Hauptthemen laut MEDLINE: Proteus mirabilis, Anti-Bacterial Agents, Urease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteus mirabilis , a significant pathogenic bacterium within the Enterobacteriaceae family, is widely distributed across various natural environments. This study conducted a genomic comparison analysis of 1,267 strains of P. mirabilis using extensive genome data from public databases. The objective was to elucidate the pan-genomic structure of P. mirabilis , revealing the composition and distribution of core and accessory gene families among different strains. Additionally, an attempt was made to construct a core genome multilocus sequence typing scheme specific to this species in order to enhance the precision of describing genetic diversity and evolutionary relationships. Furthermore, the study delved into the mechanisms of resistance of P. mirabilis to carbapenems and quinolones. Our findings underscore significant challenges posed by P. mirabilis in terms of antibiotic resistance, with widespread resistance observed particularly against beta-lactams and an increasing trend in resistance to carbapenems and quinolones. These results highlight the severity of P. mirabilis as a pathogen and underscore its rapid evolution and adaptability in developing resistance. This study aims to deepen our understanding of the antibiotic resistance of P. mirabilis , providing important insights for the development of future antimicrobial drugs, promoting effective treatment and control of this pathogen, and mitigating its threat to human health. IMPORTANCE The bacterium Proteus mirabilis is a common pathogenic bacterium that is known to cause a variety of human infections. The drug-resistant genes carried by P. mirabilis present a significant challenge to clinical treatment, particularly in regard to the organism’s notable resistance to commonly used beta-lactam and quinolone drugs. Furthermore, the prevalence of the urease gene cluster of P. mirabilis at the urease gene level may be associated with the formation of kidney stones. The objective of the study is to analyze the bacterium’s drug resistance, urease gene clusters, and gene distribution in genomes in order to facilitate the development of antimicrobial drugs and improve the treatment and control of P. mirabilis infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteus mirabilisAnti-Bacterial AgentsUreaseHumansProteus InfectionsMultilocus Sequence TypingPhylogenyGenomicsGenome, BacterialBacterial ProteinsMicrobial Sensitivity TestsQuinolonesCarbapenemsMultigene FamilyDrug Resistance, Multiple, BacterialDrug Resistance, Bacterial

Stichwörter der Autor:innen

Proteus mirabiliscgMLST markersdrug-resistanceplasmid genome predictionurease gene cluster

Substanzen

Anti-Bacterial AgentsUreaseBacterial ProteinsQuinolonesCarbapenems

Autor:innen und Institutionen

  • School of Engineering Medicine, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Interdisciplinary Innovation Institute of Medicine and Engineering, Beihang University, Beijing, China.
  • State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • University of Chinese Academy of Sciences, Beijing, China.
  • Department of Urology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • CapitalBio Technology, Beijing, China.

ORCID-Profile: Shitao Lian, Yadong Liu, Songnian Hu, Peng Yin, Zilong He

Förderung

  • MOST | National Key Research and Development Program of China (NKPs)

Zitieren

APA

Lian, S., Liu, Y., Hu, S., Shen, C., Ma, Y., Yin, P., & He, Z. (2025). Genomic insights on cgMLST markers, drug resistance, and urease cluster of Proteus mirabilis strains. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00992-24

Vancouver

Lian S, Liu Y, Hu S, Shen C, Ma Y, Yin P, et al. Genomic insights on cgMLST markers, drug resistance, and urease cluster of Proteus mirabilis strains. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00992-24

BibTeX
@article{Lian2025,
  author = {Lian, Shitao and Liu, Yadong and Hu, Songnian and Shen, Chen and Ma, Yinping and Yin, Peng and He, Zilong},
  title = {Genomic insights on cgMLST markers, drug resistance, and urease cluster of Proteus mirabilis strains},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.00992-24}
}
Kostenlos starten →